Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ginsberg

Showing results (281-290 of 312) with videos related to

Pageof 32
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2017
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic SubjectsTiffany Thomas, Haihong Zhou, Wahida Karmally, et al.
Journal of Lipid Research|April 4, 2014
Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MSYi Pan, Haihong Zhou, Ablatt Mahsut, et al.
European Heart Journal|May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Circulation|November 12, 2019
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES TrialAmy Damask, P Gabriel Steg, Gregory G Schwartz, et al.
Atherosclerosis|January 29, 2014
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular diseaseHelena Gylling, Jogchum Plat, Stephen Turley, et al.
The New England Journal of Medicine|July 1, 2010
Effects of medical therapies on retinopathy progression in type 2 diabetes, , Emily Y Chew, et al.
The New England Journal of Medicine|March 16, 2010
Effects of combination lipid therapy in type 2 diabetes mellitus, Henry N Ginsberg, Marshall B Elam, et al.
Science (New York, N.Y.)|August 31, 2023
Intracellular tPA-PAI-1 interaction determines VLDL assembly in hepatocytesWen Dai, Heng Zhang, Hayley Lund, et al.
Circulation|December 18, 2016
Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansGissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, et al.
JAMA Internal Medicine|February 5, 2014
Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trialJeff D Williamson, Lenore J Launer, R Nick Bryan, et al.
Pageof 32

Showing results (281-290 of 312) with videos related to

Sort By:
Pageof 32
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 2017
CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic SubjectsTiffany Thomas, Haihong Zhou, Wahida Karmally, et al.
Journal of Lipid Research|April 4, 2014
Static and turnover kinetic measurement of protein biomarkers involved in triglyceride metabolism including apoB48 and apoA5 by LC/MS/MSYi Pan, Haihong Zhou, Ablatt Mahsut, et al.
European Heart Journal|May 3, 2011
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementM John Chapman, Henry N Ginsberg, Pierre Amarenco, et al.
Circulation|November 12, 2019
Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES TrialAmy Damask, P Gabriel Steg, Gregory G Schwartz, et al.
Atherosclerosis|January 29, 2014
Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular diseaseHelena Gylling, Jogchum Plat, Stephen Turley, et al.
The New England Journal of Medicine|July 1, 2010
Effects of medical therapies on retinopathy progression in type 2 diabetes, , Emily Y Chew, et al.
The New England Journal of Medicine|March 16, 2010
Effects of combination lipid therapy in type 2 diabetes mellitus, Henry N Ginsberg, Marshall B Elam, et al.
Science (New York, N.Y.)|August 31, 2023
Intracellular tPA-PAI-1 interaction determines VLDL assembly in hepatocytesWen Dai, Heng Zhang, Hayley Lund, et al.
Circulation|December 18, 2016
Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansGissette Reyes-Soffer, Marianna Pavlyha, Colleen Ngai, et al.
JAMA Internal Medicine|February 5, 2014
Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trialJeff D Williamson, Lenore J Launer, R Nick Bryan, et al.
Pageof 32